Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Extraordinary progress has been made over the last decade in the treatment of multiple myeloma with the incorporation of new drugs, particularly proteasome inhibitors, immunomodulators, and monoclonal antibodies.The combined use of innovative drugs, already in the first lines of treatment, has led t...

Full description

Bibliographic Details
Main Authors: Angelo Maiolino, Luciano J. Costa, Marcelo Pasquini, Edvan de Queiroz Crusoe, Afonso Celso Vigorito, Marco Aurélio Salvino, Fernanda Salles Seguro, Jayr Schmidt Filho, Vania Tietsche de Moraes Hungria
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Multiple myeloma
Treatment
Immunotherapy
CAR-T cells
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137921001383

Internet

http://www.sciencedirect.com/science/article/pii/S2531137921001383

Similar Items